Breaking News

Sunshine Biopharma Acquires Nora Pharma

Nora Pharma expands Sunshine Biopharma's operations into the area of generic prescription drugs and biosimilars.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sunshine Biopharma, Inc., a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, has completed the acquisition of Nora Pharma Inc. for $21.9 million in cash. Effective immediately, Nora Pharma Inc. is now a wholly owned subsidiary of Sunshine Biopharma Inc.   Nora Pharma is one of North America’s fastest growing generic pharmaceuticals companies. The addition of Nora Pharma allows Sunshine Biopharma to expand its operations into the...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters